{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Famindr.com%2Fepisodes%2Fnovel-drug-development-part-3-alzheimers-disease-june-2020-1nViMVsS","width":444,"version":"1.0","type":"rich","title":"Novel Drug Development-Part 3: Alzheimer's Disease June 2020","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/9a8ef428-72db-47cb-a5cb-a6a258a13785/2837f1f6-e144-47ee-953a-5719f3a46fb5/slide1.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/ed45260c-e98f-417d-b802-ce519aafd792\" height=\"200\" width=\"100%\" title=\"Novel Drug Development-Part 3: Alzheimer&apos;s Disease June 2020\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"Having trouble keeping up with the literature in Alzheimer's Disease? We are here to help! \n\nJoseph tells you about more papers on drugs in development from June 2020.   These studies encompass those done in vitro or using computational models, but not animal testing. Here, you will hear about approaches with multiple targets: cholinesterase, amyloid-beta, tau, oxidative stress...  If you're interested in hearing more about treatments for AD, you should also check out our episodes on pre-clinical and clinical testing. "}